CD4 and cancer: Although the data published so far suggests that exhausted T cell populations within the tumor microenvironment might not be the predominant target of PD-L1/PD-1 blockade therapy, further research is needed to reveal the specific contribution of the different intra-tumoral CD4 T cell subsets to PD-L1/PD-1 blockade efficacy in different cancer types.